D-0172-2023 Class III Terminated
FDA drug recall D-0172-2023 was initiated by OurPharma LLC on Jan 13, 2023 and is designated Class III. Reason for recall: Short Fill: Underfilled units. The recall status is terminated (terminated Sep 20, 2024). Affected quantity: 768 cassettes.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 1, 2023
- Initiation Date
- Jan 13, 2023
- Termination Date
- Sep 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 768 cassettes
Product description
FentaNYL Citrate 2.5mg/50mL (50mcg/mL) Injection Solution, Preservative-Free IV Injection 50mL Cassette, Rx Only, OurPharma, LLC, 2512 S. City Lake Rd., Fayetteville, AR 72701, NDC 73013-1001-01.
Reason for recall
Short Fill: Underfilled units.
Distribution pattern
IL and MO
Code information
Lots: 100122080003, Exp. 2/26/2023; 100122090001, Exp. 3/07/2023; 100122100002, Exp. 4/05/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0172-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026